Mallinckrodt Plc (MNKKQ)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

COLLEGE BUSINESS & TECHNOLOGY PARK DUBLIN 15, IRELAND D15

Mallinckrodt Pharmaceuticals is an Irish–tax registered manufacturer of specialty pharmaceuticals , generic drugs and imaging agents. In 2017 it generated 90% of sales from the U.S. healthcare system. While Mallinckrodt is headquartered in Ireland for tax purposes, its operational headquarters are in the U.S. Mallinckrodt's 2013 tax inversion to Ireland drew controversy when it was shown Acthar, was Medicaid's most expensive drug. Mallinckrodt acquires , manufactures, and distributes products used in diagnostic procedures and in the treatment of pain and related conditions. This includes the acquisition, manufacture, and distribution of specialty pharmaceuticals, active pharmaceutical ingredients, contrast products, and radiopharmaceuticals. The company employed 5,500 and had net sales of $3.2 billion in 2017; of which $2.9 billion was from the U.S. healthcare system.

Data as of 2021-05-01 10:50:34 -0400
Market Cap21.971 Million Shares Outstanding84.505 Million Avg 30-day Volume344.053 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low0.8 / 0.0652 Next Earnings Date2021-05-04 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from MNKKQ instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 38 169 -77.51% 6 (0.36%) 34 (2.12%) -82.35%
13F shares: 2.686 Million 43.816 Million -93.87% 239.154 Thousand 16.514 Million -98.55%
% Ownership 3.1748 51.7884 -93.87% 0.2827 19.5187 -98.55%
New Positions: 6 18 -66.67% 6
Increased Positions 4 36 -88.89% 7
Closed Positions 134 37 262.16% 28 12 133.33%
Reduced Positions 7 46 -84.78% 1 11 -90.91%
Total Calls 124.872 Thousand 4.277 Million -97.08% 75 Thousand 855.4 Thousand -91.23%
Total Puts 2.927 Thousand 6.679 Million -99.96% 0 2.892 Million -100.0%
PUT/CALL Ratio 0.02 1.56 -98.72% 0.0 3.38 -100.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MNKKQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MNKKQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

58.7 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SCHAEFER KATHY A SR. VP FIN & CORP. CONTROLLER

  • Officer
22,934 2021-04-01 2

CARROLL J MARTIN

  • Director
0 2021-03-12 2

PAYA CARLOS V

  • Director
0 2021-03-12 2

HARROLD KASSIE CHIEF COMPLIANCE OFFICER

  • Officer
118 2021-02-25 1

NORTON DAVID Y

  • Director
0 2020-12-17 4

CASEY MARK J EVP AND CHIEF LEGAL OFFICER

  • Officer
32,011 2020-12-17 1

CARLUCCI DAVID R

  • Director
0 2020-12-04 2

REASONS BRYAN M. EVP & CFO

  • Officer
11,593 2020-12-03 1

O'NEILL HUGH M. EVP & CHIEF COMM & OPS OFCR

  • Officer
78,956 2020-11-16 1

RUSSELL ANGUS C.

  • Director
0 2020-11-12 2

TRUDEAU MARK PRESIDENT AND CEO

  • Officer
  • Director
11,312 2020-11-12 1

WATKINS IAN J EVP AND CHIEF HR OFFICER

  • Officer
18,282 2020-11-11 1

YOUNGBLOOD DR KNEELAND

  • Director
0 2020-11-06 2

WHITAKER ANNE CLEM

  • Director
0 2020-11-06 2

REED JOANN A

  • Director
34,065 2020-05-13 1

CARTER PAUL RUTHERFORD

  • Director
20,320 2020-05-13 1

ROMANO STEVEN J. EXEC. VP & CHIEF SCI. OFCR

  • Officer
72,637 2020-04-01 0

ROSA-BJORKESON DAGMAR CHIEF STRAT & CORP DEV OFFICER

  • Officer
23,431 2019-06-01 0

ZACCAGNINO JOSEPH A

  • Director
36,481 2019-05-15 0

HARBAUGH MATTHEW K EVP & PRESIDENT, SPEC GEN

  • Officer
104,115 2019-04-02 0

SCHOLZ FRANK EVP & CHF OPS & DIG INNOV OFF

  • Officer
89,614 2019-04-01 0

SHEEHY KAREN PATRUNO CHIEF COMPLIANCE OFFICER

  • Officer
13,936 2019-04-01 0

KEGLER GEORGE A. EVP & CFO, INTERIM

  • Officer
14,985 2019-01-09 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PARTNERS, L.P.

  • 10% Owner
  • *POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2018-05-09 0

LLOYD RONALD K. EXEC. VP & PRES, HOSPITAL

  • Officer
38,957 2018-04-02 0

GULYAS DIANE H.

  • Director
17,344 2018-03-01 0

BOOTH MELVIN D

  • Director
38,202 2018-03-01 0

PHILLIPS GARY M. EXEC. VP & CHIEF STRATEGY OFCR

  • Officer
21,178 2018-01-03 0

FISCHER MEREDITH B CHIEF PUBLIC AFFAIRS OFFICER

  • Officer
28,318 2018-01-03 0

LANNUM COLEMAN N III SR. VP INVESTOR STRATEGY & IRO

  • Officer
35,510 2018-01-03 0

HICKS MICHAEL-BRYANT GENERAL COUNSEL

  • Officer
16,342 2018-01-03 0

THOMPSON VIRGIL D

  • Director
No longer subject to file 2017-03-01 0

FUREY RAYMOND J. CHIEF COMPLIANCE OFFICER

  • Officer
6,462 2017-01-04 0

BAILEY DON M

  • Director
No longer subject to file 2016-03-16 0

LURKER NANCY

  • Director
10,507 2016-03-16 0

CARLSON TERRANCE L INTERIM GENERAL COUNSEL

  • Officer
2,549 2015-12-11 0

EDWARDS PETER G SR. VP & GENERAL COUNSEL

  • Officer
17,293 2015-05-27 0

SALTARELLI MARIO D. SR. VP & CHIEF SCIENCE OFCR.

  • Officer
6,808 2015-05-18 0

HATTEN SANDRA L SR. VP, QUALITY

  • Officer
6,642 2015-05-11 0

TASSE DANIEL INTERIM PRES-HOSPITAL BUSINESS

  • Officer
0 2015-05-01 0

PAULSON & CO INC

  • 10% Owner
No longer subject to file 2014-08-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SCHAEFER KATHY A - Officer SR. VP FIN & CORP. CONTROLLER

2021-04-05 16:24:38 -0400 2021-04-02 F 398 $0.38 d 22,934 direct

SCHAEFER KATHY A - Officer SR. VP FIN & CORP. CONTROLLER

2021-04-05 16:24:38 -0400 2021-04-01 F 277 $0.38 d 23,332 direct

CARROLL J MARTIN - Director

2021-03-16 16:17:35 -0400 2021-03-12 S 10,667 $0.40 d 0 direct

PAYA CARLOS V - Director

2021-03-16 16:26:29 -0400 2021-03-12 S 16,614 $0.40 d 0 direct

CARROLL J MARTIN - Director by trust

2021-03-16 16:17:35 -0400 2021-03-12 S 31,398 $0.40 d 0 indirect

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MALLINCKRODT PLC MNKKQ 2021-05-05 22:15:02 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 21:45:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 21:15:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 20:45:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 20:15:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 19:45:02 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 19:15:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 18:45:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 18:15:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 17:45:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 17:15:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 16:45:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 16:15:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 15:45:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 15:15:02 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 14:45:04 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 14:15:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 13:45:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 13:15:03 UTC -21.9312 21.9812 2200000
MALLINCKRODT PLC MNKKQ 2021-05-05 12:45:02 UTC -21.9312 21.9812 2200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments